Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-06-11 5:06 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 2,244,904 6.8% | -853,416 (-27.54%) | View |
| 2020-04-20 08:43 am Purchase | 13D | CRINETICS PHARMACEUTICALS INC CRNX | PERCEPTIVE ADVISORS LLC | 3,659,381 11.6% | 1,071,428 (+41.40%) | View |
| 2020-02-14 12:00 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 2,039,282 8.42% | 125,000 (+6.53%) | View |
| 2020-02-14 11:39 am Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 2,684,562 10.9% | -473,689 (-15.00%) | View |
| 2020-02-13 4:30 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 3,098,320 12.8% | -344,781 (-10.01%) | View |
| 2020-02-11 4:00 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Struthers Richard Scott | 1,503,154 6.1% | 1,503,154 (New Position) | View |
| 2020-02-07 11:16 am Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 3,633,331 14.999% | 694,792 (+23.64%) | View |
| 2020-02-05 6:27 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | 5AM Ventures IV L.P. | 2,362,286 9.8% | -1,136,992 (-32.49%) | View |